A major breakthrough in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This vital malignant inhibitor protein is frequently inactivated in many kinds of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research